MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3.11 Cr | ₹0.50 Cr | ₹0.65 Cr | ₹6.04 Cr | ₹7.84 Cr |
What is the latest Total Non-Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹3.11 Cr |
| Mar2024 | ₹0.50 Cr |
| Mar2023 | ₹0.65 Cr |
| Mar2022 | ₹6.04 Cr |
| Mar2021 | ₹7.84 Cr |
How is Total Non-Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.11 Cr | 524.95 | |
| Mar2024 | ₹0.50 Cr | -23.54 | |
| Mar2023 | ₹0.65 Cr | -89.23 | |
| Mar2022 | ₹6.04 Cr | -23.04 | |
| Mar2021 | ₹7.84 Cr | - | |
Compare Total Non-Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹479.7 Cr | -3.3% | -8.8% | -28.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -3.3% |
-8.8% |
-28.2% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses